Novartis Germany GmbH赞助的临床试验
总计295个结果
-
Charite University, Berlin, GermanyNovartis Germany GmbH完全的
-
University of KielDeutsche Forschungsgemeinschaft, Bonn, Germany; Novartis Pharma GmbH, Nürnberg, Germany完全的
-
Charite University, Berlin, GermanyGerman Research Foundation; adexter GmbH完全的
-
AbbVieIST GmbH, Germany完全的
-
AbbVieIST GmbH, Germany完全的
-
AbbVieIST GmbH, Germany完全的
-
AbbVieIST GmbH, Germany完全的
-
Universitätsklinikum Hamburg-EppendorfFederal Joint Committee; aQua-Institut GmbH, Germany; Leibniz-Institut für Resilienzforschung,... 和其他合作者主动,不招人
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, Germany完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, Germany完全的
-
AbbVieHannover Medical School; IST GmbH, Germany; Improvement by Movement GmbH, Germany终止
-
ShireNycomed Germany GmbH完全的
-
AIO-Studien-gGmbHUniversitätsklinikum Hamburg-Eppendorf; Merck Serono GmbH, Germany; Pierre Fabre Pharma GmbH招聘中大肠癌 | 结肠癌 | BRAF V600突变 | BRAF V600E | 局部癌症德国
-
GWT-TUD GmbHNovartis完全的
-
Charite University, Berlin, GermanyPfrimmer Nutricia GmbH, Erlangen , Germany完全的
-
Charite University, Berlin, GermanyPfrimmer Nutricia GmbH, Erlangen , Germany完全的
-
Charite University, Berlin, GermanyNovartis完全的
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbH招聘中
-
North Eastern German Society of Gynaecological...Novartis Pharmaceuticals; medac GmbH主动,不招人
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbH招聘中
-
Fresenius Medical Care Deutschland GmbHSiro Clinpharm Germany GmbH完全的
-
AbbVieCato Research; IST GmbH, Germany完全的
-
German Heart InstituteNovartis未知
-
DiaNe HCM GmbHRoche Pharma Deutschland GmbH, Grenzach-Wyhlen, Germany; Institute for Medical Outcom Research...完全的
-
German Breast GroupNovartis未知
-
GWT-TUD GmbHNovartis Pharmaceuticals完全的
-
Follicum ABproDERM GmbH; Hair and Skin Institute, Charité, Berlin, Germany; Centroderm GmbH, Wuppertal, Germany完全的
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH完全的神经内分泌癌,3 级 | 低分化恶性神经内分泌癌 | 转为 G3 的 1 级神经内分泌癌 [分化良好的神经内分泌癌] | 转为 G3 的 2 级神经内分泌癌 [中度分化神经内分泌癌] | 神经内分泌肿瘤,3 级和疾病进展,根据实体瘤反应评估标准 (RECIST 1.1.) 衡量德国
-
Charite University, Berlin, GermanyNovartis Pharmaceuticals完全的
-
Charite University, Berlin, GermanyNovartis Pharmaceuticals完全的
-
Charite University, Berlin, GermanyNovartis Pharmaceuticals完全的
-
University of UlmMedac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)完全的
-
Charite University, Berlin, GermanySanofi; Proinnovera GmbH完全的
-
Charite University, Berlin, GermanyEssex Pharma GmbH完全的
-
Provitro GmbHCharite University, Berlin, Germany; AstraZeneca完全的
-
Charite University, Berlin, GermanyReactive Robotics GmbH完全的
-
Charite University, Berlin, GermanyReactive Robotics GmbH完全的
-
Vaximm GmbHPfizer; Merck KGaA, Darmstadt, Germany主动,不招人
-
Charite University, Berlin, GermanySanofi; Proinnovera GmbH完全的